Molecular Imaging News and Research

RSS

Avid, Cardinal Health partner to detect Alzheimer's disease in living patients

Currently, Alzheimer's disease cannot be definitively diagnosed until after death, when a brain autopsy is performed on a patient and evidence of beta-amyloid plaque deposits in the brain – which are a characteristic pathology of the disease – can be found. Accurate diagnosis during life can be challenging, particularly in the early stages of Alzheimer's, when symptoms are mild and non-definitive. However, Avid Radiopharmaceuticals, Inc. and Cardinal Health are working together to change that.

26 Mar 2010

Eli Lilly supports SNM's initiative to advance innovative therapies

SNM is pleased to announce that biopharmaceutical company, Eli Lilly and Company, has joined SNM's Clinical Trials Network-making it the third major company to formally support this initiative to facilitate the development of promising therapeutic medicines.

26 Mar 2010

CRi to distribute 3DHISTECH’s digital slide scanners and software applications in North America

Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH’s full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi’s offerings in the rapidly growing digital pathology market.

22 Mar 2010

Global halt on Molybdenum-99 production: Discussion of implications

Discuss the severe Tc-99m shortage that will occur over a two-week period when cancer, heart and brain disease patients will experience delayed imaging tests because of a worldwide halt on Molybdenum-99 production

19 Mar 2010

Safeguard Scientifics' aggregate partner company revenue rises 46% in 2009

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the year was $262 million, up 46% from $179 million in 2008, exceeding the company’s 2009 guidance of $223 million to $243 million, as adjusted to reflect the inclusion of two new partner companies.

11 Mar 2010

Springer to publish Nuclear Medicine and Molecular Imaging

NMMI publishes original research papers, reviews, case reports, editorials and letters to the editor on nuclear medicine and a wide range of related sciences. These include radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. June-Key Chung, MD, PhD, from the Seoul National University College of Medicine will serve as editor-in-chief. He will be supported by an international editorial board.

10 Mar 2010

Endothelial cells can produce copious amounts of adult stem cells: Study

In a leap toward making stem cell therapy widely available, researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College have discovered that endothelial cells, the most basic building blocks of the vascular system, produce growth factors that can grow copious amounts of adult stem cells and their progeny over the course of weeks.

5 Mar 2010

Positron announces the sale of Attrius PET scanner to Ochsner Health System of Louisiana

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announced the sale of its AttriusTM PET scanner to Ochsner Health System of Louisiana.

5 Mar 2010

Imaging technique combining ultrasound and microscopic bubbles help visualize tumor activity at molecular level

An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular level.

2 Mar 2010

Nuclear Regulatory Commission licenses Positron facility in Fishers to handle radioactive material

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announced today that the Nuclear Regulatory Commission has licensed the Positron facility in Fishers, Indiana to handle radioactive material.

2 Mar 2010

U.S. Patent and Trademark office issues Patent on Positron’s Tech-Assist

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announced today that the U.S. Patent and Trademark office has allowed for issuance a Patent on Positron’s Tech-Assist™. The Tech-Assist™, invented under the direction of John A. Zehner, a nuclear pharmacist, dramatically reduces exposure to the worker while injecting radiopharmaceuticals into patients when performing Positron Emission Tomography (PET) imaging studies.

19 Feb 2010

Principio, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center sign technology licensing agreement

Principio Inc., a privately held emerging company developing novel molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer, today announced that the Company has obtained an exclusive license to several technologies developed at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

11 Feb 2010

Renowned experts explore latest key development in nuclear medicine and molecular imaging at 2010 SNM summit

Educators, researchers, physicians, technologists and medical experts from across the country converged on Albuquerque, N.M., last week to explore topics in nuclear medicine, molecular imaging, nanomedicine and clinical trials during SNM's 2010 Conjoint Mid-Winter Meetings.

10 Feb 2010

Study may pave way for more refined treatments for brain tumors

Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.

10 Feb 2010

FRG announces new molecular imaging division

Foundation Radiology Group (FRG), a premier provider of diagnostic imaging professional services, headquartered in downtown Pittsburgh, is pleased to announce its new division, FRG Molecular Imaging, which will be led by nationally renowned physician and PET/CT imaging pioneer, Todd M. Blodgett, M.D..

4 Feb 2010

Maximizing quality in clinical trials is emphasized at community workshop

A community workshop sponsored by SNM's Clinical Trials Network (CTN) officially kicked off on Feb. 1, in Albuquerque, N.M., and presented participants with a series of educational sessions on the use of molecular imaging in clinical trials for investigational therapeutic drugs.

3 Feb 2010

SNM Clinical Trials Network Workshop: Experts to discuss usage of molecular imaging

On Feb. 2, the final day of the second annual SNM Clinical Trials Network Workshop, experts working in various facets of the molecular imaging community met in Albuquerque, N.M., to discuss the nuts and bolts of using imaging in clinical trials and the challenges and opportunities ahead in the regulatory landscape.

3 Feb 2010

SNM's Nanomedicine and Molecular Imaging Summit examines the use of nanoparticles

SNM's Nanomedicine and Molecular Imaging Summit wrapped up today in Albuquerque, N.M., with in-depth discussion-and a high sense of energy looking ahead.

3 Feb 2010

Summit explores medical application of molecular nanotechnology

Albuquerque's blue skies and majestic mountains provided a scenic backdrop for a summit that explores one of the most promising technologies on the horizon--nanomedicine, or the medical application of molecular nanotechnology--a still-developing science dedicated to constructing microscopic probes and biomechanical devices.

2 Feb 2010

Agent-enhanced CT scan plays a supporting role in diagnosing severe cases of H1N1 flu virus

Published reports on the usefulness of CT scans for complicated H1N1 cases have spurred use of these procedures in U.S. hospitals. According to healthcare market research publisher Kalorama Information, this opens up a pathway of diagnostics for physicians and overall is a positive sign not only for the technology but also for companies making chemical agents for procedures.

29 Jan 2010

Molecular Imaging News and Research

Avid, Cardinal Health partner to detect Alzheimer's disease in living patients

Eli Lilly supports SNM's initiative to advance innovative therapies

CRi to distribute 3DHISTECH’s digital slide scanners and software applications in North America

Global halt on Molybdenum-99 production: Discussion of implications

Safeguard Scientifics' aggregate partner company revenue rises 46% in 2009

Springer to publish Nuclear Medicine and Molecular Imaging

Endothelial cells can produce copious amounts of adult stem cells: Study

Positron announces the sale of Attrius PET scanner to Ochsner Health System of Louisiana

Imaging technique combining ultrasound and microscopic bubbles help visualize tumor activity at molecular level

Nuclear Regulatory Commission licenses Positron facility in Fishers to handle radioactive material

U.S. Patent and Trademark office issues Patent on Positron’s Tech-Assist

Principio, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center sign technology licensing agreement

Renowned experts explore latest key development in nuclear medicine and molecular imaging at 2010 SNM summit

Study may pave way for more refined treatments for brain tumors

FRG announces new molecular imaging division

Maximizing quality in clinical trials is emphasized at community workshop

SNM Clinical Trials Network Workshop: Experts to discuss usage of molecular imaging

SNM's Nanomedicine and Molecular Imaging Summit examines the use of nanoparticles

Summit explores medical application of molecular nanotechnology

Agent-enhanced CT scan plays a supporting role in diagnosing severe cases of H1N1 flu virus

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News